RBC Capital analysts provided their outlook on Nutanix, Inc. (NASDAQ:NTNX) ahead of the upcoming Q1 results, expected to be announced on Nov 30.
The analysts expect in-line results following stabilizing Q4/22 dynamics. While macro challenges remain, the analysts said they will be watching for further consistency/improvements around renewals, sales attrition following a new CRO and the new product portfolio.
With the increased focus on profitable growth, they will also watch for the trajectory to positive free cash flow/operating income with both guided to be positive for fiscal 2023.
The analysts raised their price target on the company’s shares to $31 from $24 while maintaining their Outperform rating.
At CWEB, we are always looking to expand our network of strategic investors and partners. If you're interested in exploring investment opportunities or discussing potential partnerships and serious inquiries. Contact: jacque@cweb.com